the discussants reply: Dr. Blum questions the rationale for the use of isoniazid, rifampin, and moxifloxacin for the treatment of this patient who had drug-sensitive tuberculosis. Although we are happy to provide our rationale, providing evidence to support it is another story, as is often the case for clinical decision-making related to the treatment of tuberculosis.
展开▼